Enabling continuous, global insight – without survey fatigue or platform complexity
Client
Pharmaceuticals by Baxter – European Medical Affairs
The challenge
As a large, global pharmaceutical organisation, Pharmaceuticals by Baxter’s European Medical Affairs team works closely with pharmacists and healthcare professionals across multiple markets to build a detailed understanding of real-world clinical practice – including workflow patterns, methodological preferences, regional variation, real-world use of products/therapies, and practitioner expectations of new and evolving clinical solutions.
For the European Medical Affairs and product teams, this insight is critical – not just for communications, but for early product development, refinement, and engagement strategy.
Historically, gathering this input presented several challenges:
- insights were fragmented across different departments and geographies
- comparing results over time was difficult
- engagement varied across regions and cohorts
- traditional surveys felt generic and impersonal
Before adopting EveryView, much of this input was informal. The European Medical Affairs team wanted to reduce reliance on assumption-led thinking and replace it with structured, professional engagement – capturing consistent insight directly from practitioners at scale.
The approach
Pharmaceuticals by Baxter’s European Medical Affairs team adopted EveryView as a structured practitioner insight platform, using it to run ongoing pulse and pre-market insight programmes with defined cohorts of pharmacists and healthcare professionals.
The platform is used primarily to support early product and service development, enabling Baxter to gather structured pre-market insight into:
- what practitioners value in practice
- what they want to avoid
- how medicines and therapies are currently being used
- where workflow friction exists
- which improvements would have the greatest real-world impact
Rather than relying on one-off research exercises or anecdotal feedback, EveryView enables the European Medical Affairs team to build continuous, professional engagement with practitioners and generate comparable insight over time.
The team uses EveryView to maintain ongoing engagement with defined practitioner cohorts, returning to the same groups over time to explore clinical, dispensing, and workflow scenarios in a structured way. The platform supports the collection of practitioner feedback on products and services at different stages of development, helping teams refine early-stage concepts and make more informed decisions.
Because insight is gathered consistently and in a structured format, the European Medical Affairs team can compare responses across regions, roles, and professional settings, while also tracking how practitioner opinion and behaviour evolve over time. Use cases span multiple care environments – question sets are adapted to each context, but the insight model remains consistent and comparable.
All data is captured within a single environment, enabling connected, longitudinal insight rather than isolated snapshots.
Why EveryView
EveryView offers clear advantages over generic survey platforms:
-
Designed for pharma audiences: A bespoke, credible environment built for regulated expert engagement.
-
Multilingual by design: Participants can respond in their own language without breaking dataset coherence.
-
Cohort continuity: The same practitioner groups can be engaged over time without rebuilding workflows.
-
Structured insight + AI assistance: AI-supported summarisation and pattern detection reduce manual analysis time while keeping expert input central.
-
Participant experience: Practitioners consistently report that the platform is easy to use.
The commercial model
Pharmaceuticals by Baxter’s European Medical Affairs team adopted EveryView on an annual licence model, allowing for:
- multiple insight programmes per year
- defined internal user access
- global participation across markets
This provides predictable cost, flexible usage, and a low barrier to scaling adoption across additional teams and use cases.
The impact
Using EveryView has enabled Pharmaceuticals by Baxter’s European Medical Affairs team to:
-
- replace anecdotal assumptions with structured practitioner insight
- inform product and service development with real-world evidence
- engage pharmacists and healthcare professionals continuously
- achieve consistently high participation and response rates
- gather insight quickly and consistently across markets
- compare data across time and geography
- strengthen practitioner collaboration and engagement
The result is not just more data – but more credible, decision-ready insight.
"EveryView gives us structured, professional insight directly from the people using our products"
Why it matters
For global pharmaceutical organisations, insight is most valuable when it is structured, repeatable, and practitioner-led.
By using EveryView as a continuous insight platform – particularly in pre-market and product development contexts – Pharmaceuticals by Baxter’s European Medical Affairs team has created a scalable, credible way to listen to practitioners and act on what they learn.